Status:
COMPLETED
The Effect of Tapping in the Venous Dilatation for Peripheral IV Access
Lead Sponsor:
University of Florida
Conditions:
Catheterization, Peripheral
Venous Dilatation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Peripheral intravenous cannulation (PIVC) is one of the most common interventions in medical practice. Venous dilatation is helpful for successful PIV placement. Several techniques include hot pack ap...
Detailed Description
PIVC is one of the most common medical interventions in daily practice. Even though it seems like it should be an easy procedure, PIVC can be challenging. Venous dilatation optimizes conditions for s...
Eligibility Criteria
Inclusion
- \>18 years old,
- Giving informed consent,
- COVID-19 vaccinated (proof of vaccination must be shown)
Exclusion
- COVID-19 unvaccinated,
- Having unexplained COVID symptom(s) (This will be assessed by asking the ONE.UF screening questions):
- Fever or chills
- Cough
- Fatigue
- Muscle or body aches
- Headache
- New loss of taste or smell
- Sore throat
- Congestion or runny nose
- Nausea or vomiting
- Diarrhea
- Close contact with a COVID-19 patient in 14 days
Key Trial Info
Start Date :
November 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05265481
Start Date
November 7 2021
End Date
June 1 2022
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32601